Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fusco

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Transboundary and Emerging Diseases|May 13, 2017
Molecular detection and phylogenetic analysis of hepatitis E virus strains circulating in wild boars in south-central ItalyG Aprea, M G Amoroso, I Di Bartolo, et al.
Applied and Environmental Microbiology|February 8, 2006
Diversity of microorganisms within rock varnish in the Whipple Mountains, CaliforniaK R Kuhlman, W G Fusco, M T La Duc, et al.
Environmental Research|July 25, 2021
A potential risk assessment tool to monitor pathogens circulation in coastal watersB Cioffi, G Ianiro, D Iaccarino, et al.
Science Advances|November 20, 2024
Hepatovirus translation requires PDGFA-associated protein 1, an eIF4E-binding protein regulating endoplasmic reticulum stress responsesTakayoshi Shirasaki, Erik Lenarcic, Ichiro Misumi, et al.
Clinics (Sao Paulo, Brazil)|July 2, 2020
Overcoming barriers to providing comprehensive inpatient care during the COVID-19 pandemicAnna Miethke-Morais, Beatriz Perondi, Leila Harima, et al.
Plos Pathogens|August 15, 2022
Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIXTakayoshi Shirasaki, Hui Feng, Helen M E Duyvesteyn, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
cGAS bends unpaired DNA to form an unconventional structure that hyperactivates the innate immune responseShuangshuang Yang, Shuai Wu, Silian Chen, et al.
Clinics (Sao Paulo, Brazil)|December 18, 2022
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster doseRosa M R Pereira, Marilia A Dagostin, Valeria F Caparbo, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Transboundary and Emerging Diseases|May 13, 2017
Molecular detection and phylogenetic analysis of hepatitis E virus strains circulating in wild boars in south-central ItalyG Aprea, M G Amoroso, I Di Bartolo, et al.
Applied and Environmental Microbiology|February 8, 2006
Diversity of microorganisms within rock varnish in the Whipple Mountains, CaliforniaK R Kuhlman, W G Fusco, M T La Duc, et al.
Environmental Research|July 25, 2021
A potential risk assessment tool to monitor pathogens circulation in coastal watersB Cioffi, G Ianiro, D Iaccarino, et al.
Science Advances|November 20, 2024
Hepatovirus translation requires PDGFA-associated protein 1, an eIF4E-binding protein regulating endoplasmic reticulum stress responsesTakayoshi Shirasaki, Erik Lenarcic, Ichiro Misumi, et al.
Clinics (Sao Paulo, Brazil)|July 2, 2020
Overcoming barriers to providing comprehensive inpatient care during the COVID-19 pandemicAnna Miethke-Morais, Beatriz Perondi, Leila Harima, et al.
Plos Pathogens|August 15, 2022
Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIXTakayoshi Shirasaki, Hui Feng, Helen M E Duyvesteyn, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
cGAS bends unpaired DNA to form an unconventional structure that hyperactivates the innate immune responseShuangshuang Yang, Shuai Wu, Silian Chen, et al.
Clinics (Sao Paulo, Brazil)|December 18, 2022
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster doseRosa M R Pereira, Marilia A Dagostin, Valeria F Caparbo, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Pageof 9